about
Primary immunodeficiencies associated with eosinophiliaRole of apoptosis in diseaseDouble-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineupErythematous rash following romiplostim administration in a patient with autoimmune lymphoproliferative syndrome.Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production.Autoimmune pancreatitis in the autoimmune lymphoproliferative syndrome (ALPS): a sheep in wolves' clothing?Genetic characterization of two gain-of-function alleles of the effector caspase DrICE in DrosophilaGenetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations.Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment.Diagnostic approach to primary immunodeficiency disorders.Programmed cell death and the immune system.TCF1 deficiency ameliorates autoimmune lymphoproliferative syndrome (ALPS)-like phenotypes of lpr/lpr mice.On How Fas Apoptosis-Independent Pathways Drive T Cell Hyperproliferation and Lymphadenopathy in lpr Mice.Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms.Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).Stabilized β-Catenin Ameliorates ALPS-Like Symptoms of B6/lpr Mice.Murine DX5NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4CD62L T Cells through Fas Ligand
P2860
Q26746046-3ECBB7BF-E377-43C7-A221-0C70C2EC8182Q26865637-D566052B-4579-4897-8064-28C23473DA4FQ27010540-01AE765F-5186-41E2-8711-A9CA1FB5D64CQ33405179-58BA3389-38D8-465E-AC47-BE0005D75318Q33420245-524C3DBC-DBF5-430E-BC4C-D87EFE9F371EQ34877991-C6A4AF0A-AAB8-41C1-A116-8D11BA0D089FQ36612341-A679772D-E90B-4ED3-A450-CE1532024AD1Q37179339-AAE1AE55-898F-4FFB-9561-447C7D925411Q38053490-D59324C8-7CE3-446B-969F-2C674668179EQ38096060-C8913CD6-B5FA-4B95-A0C4-5060BCC638A0Q38128689-D6589D8E-4B94-46BF-AAD6-B630E8876EB7Q39120700-699CF85D-85A0-4366-800C-79EAF81A07BFQ39609044-3B8F35DC-00ED-4A53-B6E5-7BA757BFE038Q41942913-510DE0DD-8AFE-47F4-A71A-260D98788605Q42583748-17DC44B3-1272-4A48-9A22-D734D4E7097FQ42700395-C96B5A98-1D7F-4CFA-8D52-243847FE03F3Q47136733-C9627CCF-70F0-4CD5-970D-99737A3C4DF6Q58604257-B5073A63-B1D6-4A66-8B58-6B49900A9C44
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in autoimmune lymphoproliferative syndromes.
@en
Advances in autoimmune lymphoproliferative syndromes.
@nl
type
label
Advances in autoimmune lymphoproliferative syndromes.
@en
Advances in autoimmune lymphoproliferative syndromes.
@nl
prefLabel
Advances in autoimmune lymphoproliferative syndromes.
@en
Advances in autoimmune lymphoproliferative syndromes.
@nl
P2093
P2860
P1476
Advances in autoimmune lymphoproliferative syndromes.
@en
P2093
Kanjaksha Ghosh
Manisha Madkaikar
Maya Gupta
Snehal Mhatre
P2860
P356
10.1111/J.1600-0609.2011.01617.X
P577
2011-07-01T00:00:00Z